MEDCATH CORP (MDTH) is a publicly traded company in the Unknown sector. Across all available filings, 42 corporate insiders have executed 382 transactions totaling $1.2B, demonstrating a bearish sentiment with -$901.8M in net insider flow. The most recent transaction on Sep 30, 2011 involved a transaction of 4,434 shares valued at $61.5K.
No significant insider buying has been recorded for MDTH in the recent period.
No significant insider selling has been recorded for MDTH in the recent period.
Based on recent SEC filings, insider sentiment for MDTH is bearish with an Insider Alignment Score of 12/100 and a net flow of -$901.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at MEDCATH CORP (MDTH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 42 insiders are actively trading MDTH stock, having executed 382 transactions in the past 90 days. The most active insider is Bruce K. Anderson (Executive), who has made 8 transactions totaling $107.8M.
Get notified when executives and directors at MDTH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 30, 2011 | Ramsey Lora | Executive | Payment | 4,434 | $13.88 | $61.5K | |
| Sep 30, 2011 | A. Parker James | Executive | Payment | 6,435 | $13.88 | $89.3K | |
| Sep 30, 2011 | Mccanless Joan | Executive | Payment | 6,374 | $13.88 | $88.5K | |
| Sep 30, 2011 | Daniel Perritt Paul | Executive | Payment | 2,491 | $13.88 | $34.6K | |
| Sep 23, 2011 | Edwin French O. | Executive | Payment | 28,695 | $13.67 | $392.3K | |
| Sep 12, 2011 | Fund, Lp Diii Offshore | Executive | Sale | 356,732 | $13.26 | $4.7M | Large |
| Sep 12, 2011 | Fund, Lp Diii Offshore | Executive | Sale | 137,586 | $13.26 | $1.8M | Large |
| Sep 12, 2011 | Fund, Lp Diii Offshore | Executive | Sale | 1,167,097 | $13.26 | $15.5M | Large |
| Sep 12, 2011 | Fund, Lp Diii Offshore | Executive | Sale | 312,074 | $13.26 | $4.1M | Large |
| Sep 9, 2011 | Fund, Lp Diii Offshore | Executive | Sale | 70,000 | $13.46 | $942.2K | Large |
| Sep 9, 2011 | Fund, Lp Diii Offshore | Executive | Sale | 125,000 | $13.46 | $1.7M | Large |
| Sep 9, 2011 | Fund, Lp Diii Offshore | Executive | Sale | 33,000 | $13.46 | $444.2K | |
| Sep 9, 2011 | Fund, Lp Diii Offshore | Executive | Sale | 220,000 | $13.46 | $3.0M | Large |
| Aug 1, 2011 | G. Bailey Pamela | Executive | Payment | 11,795 | $13.05 | $153.9K | |
| Aug 1, 2011 | Casey John | Executive | Payment | 11,795 | $13.05 | $153.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 166 | $1.0B | 86.9% |
Purchase(P) | 74 | $140.0M | 11.7% |
Exercise(M) | 88 | $7.9M | 0.7% |
Award(A) | 30 | $6.0M | 0.5% |
Payment(F) | 24 | $3.6M | 0.3% |
Insider selling pressure at MEDCATH CORP has increased, with 42 insiders executing 382 transactions across all time. Total sales of $1.0B significantly outpace purchases of $140.0M, resulting in a net outflow of $901.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.